Cargando…
Heightened metabolic responses in NK cells from patients with neuroblastoma suggests increased potential for immunotherapy
High risk neuroblastoma is responsible for 15% of deaths in pediatric cancer patients. The introduction of anti-GD2 immunotherapy has significantly improved outcomes but there is still only approximately a 50% 5 year event-free-survival for these children and improvements in treatments are urgently...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585418/ https://www.ncbi.nlm.nih.gov/pubmed/36276144 http://dx.doi.org/10.3389/fonc.2022.1004871 |